Inducing Angiogenesis

Slides:



Advertisements
Similar presentations
Angiogenesis.
Advertisements

A M.I.N.Y. MOUSE Production: Munasha, Ivan, Noor, Yuna Also featuring: Stephen M. and Julie R.
Tumors and Blood Vessels By: Dimitri, Amy, Idil, Bianca.
BioSci 145A lecture 18 page 1 © copyright Bruce Blumberg All rights reserved BioSci 145A Lecture 18 - Oncogenes and Cancer Topics we will cover today.
Figure 13.2 The Biology of Cancer (© Garland Science 2007) Hodgkins Lymphoma – A Cancer in Which 99% of the Tumor Cells Are Not Cancer Cells.
Dialogue Replaces Monologue:
MBBS Cancer Biology Module 2006 Tumour Vasculature and Therapeutic Strategies Barbara Pedley.
ANTIANGIOGENESIS Anticancer Therapy By: Laura Roberts.
วัตถุประสงค์ สามารถอธิบายขั้นตอนการสร้างหลอดเลือดพร้อมทั้งบอก บทบาทของโปรตีนที่เกี่ยวข้องได้ สามารถอธิบายขั้นตอนการสร้างหลอดเลือดพร้อมทั้งบอก บทบาทของโปรตีนที่เกี่ยวข้องได้
Angiogenesis ↓ Metastasis. Angiogenesis--- The process of developing new blood vessels. Cancer cells (probably like all tissues) secrete substances that.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
 Regulation of Cell Number and Cancer Cells Special Limited Edition Packet Tuesday, November 10,
ANGIOGENESIS Vasculogenesis: Embryonic development from endothelial precursors called ‘angioblasts’ Angiogenesis/ neovascularization: Process of blood.
Signal transduction: receptor gene
Fibroblast Growth Factors (FGFs)
Chapter 14: Signaling Pathways That Control Gene Activity
Tyrosine Kinases as Targets for Cancer Therapy Krause DS, Van Etten RA N Engl J Med 2005;353(2): Krause DS, Van Etten RA N Engl J Med 2005;353(2):
Oncogenes Lecture 43BSCI 420,421,620Dec 13, 2002 “It ain’t over till the fat lady sings” – Joe Gibbs 1.Cancer-critical genes a. Oncogenes b. Tumor-suppressor.
TUMOR ANGIOGENESIS. Formation of new blood vessels is called angiogenesis Tumor angiogenesis is the proliferation of a network of blood vessels that penetrates.
Date of download: 6/3/2016 Copyright © American College of Chest Physicians. All rights reserved. Tissue Factor, Thrombin, and Cancer * Chest. 2003;124(3_suppl):58S-68S.
Professor of Pathology
Lung Cancer Tumour Markers
Von Hippel-Lindau Syndrome
Figure 1. Resistance mechanism against first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). (A) Mutations in the EGFR.
Introduction to Receptors
Trans. Vis. Sci. Tech ;5(2):10. doi: /tvst Figure Legend:
Sprouting angiogenesis
Arne R. M. van der Bilt, Elisabeth G. E
Angiogenesis and hepatocellular carcinoma
Volume 76, Issue 9, Pages (November 2009)
Tissue repair (3&4 of 4) Ali Al Khader, M.D. Faculty of Medicine
Inducing Angiogenesis
Activating Invasion and Metastasis
Activating Invasion and Metastasis
Sustaining Proliferative Signaling and Evading Growth Suppressors
M.B.Ch.B, MSC, DCH (UK), MRCPCH
by Donna Nichol, and Heidi Stuhlmann
Extracellular Regulation of Apoptosis
Management of advanced renal cancer
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 A schematic representation of the HER2 signalling pathway
Angiogenesis.
Nat. Rev. Nephrol. doi: /nrneph
Bhagelu Ram Achyut, Li Yang  Gastroenterology 
Inflammation, Epithelial to Mesenchymal Transition, and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance  Kostyantyn Krysan, PhD,
Basic and Therapeutic Aspects of Angiogenesis
Angiogenesis and hepatocellular carcinoma
Environmental Carcinogenesis
Peter Celec, Yoshikazu Yonemitsu  Pathophysiology 
Vascular Endothelial Growth Factor (VEGF) Pathway
Understanding the Importance of Smart Drugs in Renal Cell Carcinoma
Volume 76, Issue 9, Pages (November 2009)
Pro-endometriotic niche in endometriosis
Figure 1 The VEGF family of growth factors
Cell division is highly regulated
ID Proteins Regulate Diverse Aspects of Cancer Progression and Provide Novel Therapeutic Opportunities  Radhika Nair, Wee Siang Teo, Vivek Mittal, Alexander.
Angiogenesis: A Team Effort Coordinated by Notch
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer  Thomas Winder, Heinz–Josef.
M.B.Ch.B, MSC, PhD, DCH (UK), MRCPCH
Oncogenes and Angiogenesis: Signaling Three-Dimensional Tumor Growth
Process and mechanisms of blood vessel formation.
SRC and STAT Pathways Journal of Thoracic Oncology
Pathogenesis of idiopathic pulmonary fibrosis (IPF).
Kristy Red-Horse, Yongping Crawford, Farbod Shojaei, Napoleone Ferrara 
Jair Bar, MD, PhD, Glenwood D. Goss, MD, FCPSA, FRCPC 
Figure 4 Bile-acid-induced TGR5 signalling pathways in macrophages
The VEGF Family, the Inside Story
EMT and proteinuria as progression factors
Volume 76, Issue 5, Pages (September 2009)
Notch signaling from tumor cells: A new mechanism of angiogenesis
Presentation transcript:

Inducing Angiogenesis Oct 31, 2017

Hallmarks of Cancer, 2011

Angiogenesis -the process of forming new blood vessels from pre-existing ones by growth and migration of epithelial cells -Common during embryogenesis but not in adults (wound healing) -diffusion limit of oxygen (100-200 um)

Necrosis Cells within the core of the tumor that do not receive oxygen or nutrients undergo cell death or necrosis

Blood Vessel Structure

Cancer vs. Wound Healing Cancer Wound Healing Neovasculature Leaky allowing cells Not leaky to enter Molecular markers Integrins are Normal level of upregulated Integrins Extracellular matrix Angiogenic markers Different markers

Angiogenic Switch Angiogenic Inhibitors Angiogenic Inducers

Angiogenic Switch Result: Angiogenesis Angiogenic Inhibitors Angiogenic Inducers Result: Angiogenesis

Angiogenic Inducers and Inhibitors Inhibitors Inducers Angiostatin VEGF Endostatin FGF Prolactin HGF p53 EGF Thrombospondins PDGF

Angiogenic Inducers VEGF and VEGF Receptor -Initiation of Angiogenesis Angiopoietins and Tie Receptor -Vessel Maturation Ephrins and Ephrin Receptor

VEGF Family -5 members -VEGF-A to D -PlGF (Placental Growth Factor) -3 Receptors -VEGFR-1, 2 and 3 -VEGF-A and VEGFR-2 are major players -VEGFR-1 acts as a decoy competing with VEGF-R2 -weak kinase activity -VEGFR-3 and VEGF-C are involved with development of the lymphatic system

VEGF-A -Secreted by tumor cells -Secretion by neighboring non-transformed cells -Induced by the tumor cells -Stores of VEGF-A in the Extracellular matrix released by metalloproteinases (MMP) -proteases whose catalysis involves a metal ion Functions of VEGF-A Promote endothelial cell proliferation Induce permeability and leakage in existing blood vessels -important for new blood vessel formation

VEGF-A Signaling Pathway

EGF Signaling Pathway

VEGF-A Responsive Genes EGFR ligand Epiregulin (EGF family member) COX2, a cyclooxygenase involved with prostaglandin formation MMP1 and MMP2

Metalloproteinases

Metalloproteinases

Angiogenic Inhibitors 1. Angiostatin 2. Endostatin 3. Thrombospondin-1

Angiostatin Stored as an inactive molecule within another molecule, Plaminogen Angiostatin binds to Annexin II to cause inhbition Cleavage

Angiostatin Stored as an inactive molecule within another molecule, Plaminogen Angiostatin binds to Annexin II to cause inhbition

Endostatin -Fragment of Collagen XVIII -Endostatin will block MMPs and MAPK

Concomitant Resistance A tumor is removed and dominant metastases are often activated Inhibition of micrometastases by Angiogenesis inhibitors from the tumor Once the tumor is removed the inhibitory signal is lost and there is also an increase in growth factors Angiostatin Endostatin

Angiogenic Switch Oxygen Sensor -HIFα and HIFβ are constitutively expressed -HIFα and HIFβ ativity is regulated by oxygen concentration -von Hippel-Lindau (VHL) tumor suppressor protein, a ubiquitin ligase Hypoxia Response Element

Oncogenic Proteins ~30 oncoproteins promote angiogenesis Growth factors -Stimulate growth of tumor cells, autocrine -Stimulate growth of endothelial cells, paracrine Receptor Tyrosine kinases (EGFR) Intracellular tyrosine kinases (Src) Intracellular transducers (Ras) Transcripition factors (Fos and Jun)

Tumor Suppressor Proteins Thrombospondin-1 prevents VEGFR Activation

Angiogenic Sprouting -Filopodia extend from endothelial cells towards the VEGF signal -VEGF-A/VEGFR-2 becomes activated -Signal is enhanced by Nrp1, a co-receptor

Angiogenic Sprouting -Filopodia extend from endothelial cells towards the VEGF signal -VEGF-A/VEGFR-2 becomes activated -Signal is enhanced by Nrp1, a co-receptor

Angiogenic Sprouting -Tip cells induce expression of Notch (DLL-4) and its release -Notch binds to its receptor on neighboring cells -Notch Receptor Intracellular domain (NICD) is released and is transported to the nucleus to repress VEGFR-2 and turns on VEGFR-1

Angiogenic Sprouting -Notch Receptor Intracellular domain (NICD) is released and is transported to the nucleus to repress VEGFR-2 and turns on VEGFR-1 -VEGFR-1 acts as a VEGF trap, reducing VEGF concentration and reducing VEGFR-2 activation -The growing sprout moves along the VEGF gradient

Angiogenic Sprouting

Angiogenic Sprouting -When 2 tips meet, they fuse, connecting the lumen and allowing blood flow